Scott Dunseth Myers
Chief Executive Officer at Viridian Therapeutics Inc.
Sits on 3 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 3 boards, counting each seat separately. Longest: Cartesian Therapeutics Inc., 3 years.
Chief executive roles
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 16, 2026 | Zentalis Pharmaceuticals Inc. | Grant or award | +57,100 | — | — |
| Jun 17, 2025 | Zentalis Pharmaceuticals Inc. | Grant or award | +57,603 | — | — |
| Apr 30, 2025 | Zentalis Pharmaceuticals Inc. | Open-market purchase | +21,000 | $1.40 | $29,400 |
| Nov 13, 2024 | Zentalis Pharmaceuticals Inc. | Grant or award | +260,192 | — | — |
| Apr 12, 2023 | Viridian Therapeutics Inc. | Open-market purchase | +4,000 | $25.37 | $101,480 |
| Mar 13, 2023 | Viridian Therapeutics Inc. | Open-market purchase | +5,500 | $29.15 | $160,325 |
| Feb 6, 2023 | Viridian Therapeutics Inc. | Grant or award | +250,000 | — | — |
Questions about Scott Dunseth Myers
What boards is Scott Dunseth Myers on?
Scott Dunseth Myers sits on the boards of Cartesian Therapeutics Inc., Viridian Therapeutics Inc. and Zentalis Pharmaceuticals Inc.
Has Scott Dunseth Myers been a CEO?
Yes — Scott Dunseth Myers was CEO of Viridian Therapeutics Inc. (2023 – 2023).
How long has Scott Dunseth Myers served on boards?
Our records show at least 10 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.